Claus Koelblinger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Claus Koelblinger has a total of 37 co-authors. Here are the top co-authors by number of shared publications:
- Michael Weber
Department of Biomedical Imaging and Image-Guided Therapy, Medical University of Vienna, Waehringer Guertel 18–20, 1090 Vienna, Austria
5 shared publications Christina Plank
Medical University of Vienna
2 shared publicationsVanessa Berger-Kulemann
Department of Radiology, Medical University of Vienna, Waehringerguertel 18-20, A-1090 Vienna, Austria
2 shared publicationsWolfgang Schima
KH Goettlicher Heiland
2 shared publications- A. Ba-Ssalamah1 shared publication
Ahmed Ba-Ssalamah
1 shared publication
Latest Publications
- 11 January 2013
- Published by Walter de Gruyter GmbH in Journal of Perinatal Medicine
- Vol. 41 (4) , 437-443
Fetal magnetic resonance imaging of lymphangiomas
Objectives: To evaluate the fetal magnetic resonance imaging findings of lymphangiomas. Methods: The magnetic resonance scans of eight fetuses with lymphangiomas were evaluated. Magnetic resonance evaluation included: number; size; signal intensities of the lesions; thickness of the septae; configuration of the margins; presence of blood breakdown products; change in size or signal intensity (in four patients with multiple examinations); exact expansion of the lesions to the adjacent anatomical structures; and concomitant pathological findings. Results were compared with postpartum clinical assessment and imaging in seven patients and with autopsy in one patient. Results: Two retroperitoneal, three thoracic, and three cervical lymphangiomas (diameters between 3.3 and 15.6 cm) were included. All lesions consisted of macrocysts, and additional microcystic parts were found in three lymphangiomas. Blood breakdown products were found in one lesion. Agreement with postpartum imaging was excellent. One patient received intrauterine drainage for chylothorax, and one pregnancy was terminated. Conclusions: Fetal lymphangiomas display the same magnetic resonance imaging features as postnatal lymphangiomas. Intrauterine magnetic resonance characterization of lymphangiomas provides the exact delineation, detection of associated and/or concomitant pathologies, and differential diagnosis among other cystic pathologies. Patient management may be altered with respect to the type and/or time of treatment, and with regard to the continuation or termination of pregnancy.
- 11 January 2013
- Published by Walter de Gruyter GmbH in Journal of Perinatal Medicine
- Vol. 41 (4) , 437-443
Fetal magnetic resonance imaging of lymphangiomas
Objectives: To evaluate the fetal magnetic resonance imaging findings of lymphangiomas. Methods: The magnetic resonance scans of eight fetuses with lymphangiomas were evaluated. Magnetic resonance evaluation included: number; size; signal intensities of the lesions; thickness of the septae; configuration of the margins; presence of blood breakdown products; change in size or signal intensity (in four patients with multiple examinations); exact expansion of the lesions to the adjacent anatomical structures; and concomitant pathological findings. Results were compared with postpartum clinical assessment and imaging in seven patients and with autopsy in one patient. Results: Two retroperitoneal, three thoracic, and three cervical lymphangiomas (diameters between 3.3 and 15.6 cm) were included. All lesions consisted of macrocysts, and additional microcystic parts were found in three lymphangiomas. Blood breakdown products were found in one lesion. Agreement with postpartum imaging was excellent. One patient received intrauterine drainage for chylothorax, and one pregnancy was terminated. Conclusions: Fetal lymphangiomas display the same magnetic resonance imaging features as postnatal lymphangiomas. Intrauterine magnetic resonance characterization of lymphangiomas provides the exact delineation, detection of associated and/or concomitant pathologies, and differential diagnosis among other cystic pathologies. Patient management may be altered with respect to the type and/or time of treatment, and with regard to the continuation or termination of pregnancy.
- 9 November 2012
- Published by Springer Nature in European Radiology
- Vol. 23 (4) , 938-942
C-arm CT during hepatic arteriography tumour-to-liver contrast: intraindividual comparison of three different contrast media application protocols
To compare tumour-to-liver contrast (TLC) of C-arm CT during hepatic arteriography (CACTHA) acquired using three protocols in patients with HCC. This prospective study was IRB approved and informed consent was obtained from each patient. Twenty-nine patients (mean age, 68 ± 7 years; 27 men) with 55 HCCs (mean diameter, 2.6 ± 1.5 cm) underwent three different CACTHA protocols in random order before chemoembolisation. Contrast medium (100 mg iodine/ml) was injected into the common hepatic artery (flow rate 4 ml/s). The imaging delay for the start of the CACTHA examination was 4 s (protocol A), 8 s (protocol B) and 12 s (protocol C) (total amount of injected contrast medium: 48 ml, 64 ml, 80 ml). TLC was measured by placing regions of interest (ROIs) in the HCC and liver parenchyma. Mixed model ANOVAs and Bonferroni corrected post hoc tests were used for statistical analysis. Mean values for TLC were 132 ± 3.3 HU, 186 ± 5.8 HU and 168 ± 2.8 HU for protocols A, B and C. Protocol B provided significantly higher TLC than protocols A and C (p < 0.001). TLC was significantly higher using an imaging delay of 8 s compared with a delay of 4 or 12 s. • C-arm cone-beam CT (CACT) angiography offers additional information during hepatic intervention. • CACT hepatic arteriography tumour-to-liver contrast is highest with an 8-s delay. • An 8-s delay is recommended for early arterial phase CACTHA for hepatocelullar carcinoma.
- 9 November 2012
- Published by Springer Nature in European Radiology
- Vol. 23 (4) , 938-942
C-arm CT during hepatic arteriography tumour-to-liver contrast: intraindividual comparison of three different contrast media application protocols
To compare tumour-to-liver contrast (TLC) of C-arm CT during hepatic arteriography (CACTHA) acquired using three protocols in patients with HCC. This prospective study was IRB approved and informed consent was obtained from each patient. Twenty-nine patients (mean age, 68 ± 7 years; 27 men) with 55 HCCs (mean diameter, 2.6 ± 1.5 cm) underwent three different CACTHA protocols in random order before chemoembolisation. Contrast medium (100 mg iodine/ml) was injected into the common hepatic artery (flow rate 4 ml/s). The imaging delay for the start of the CACTHA examination was 4 s (protocol A), 8 s (protocol B) and 12 s (protocol C) (total amount of injected contrast medium: 48 ml, 64 ml, 80 ml). TLC was measured by placing regions of interest (ROIs) in the HCC and liver parenchyma. Mixed model ANOVAs and Bonferroni corrected post hoc tests were used for statistical analysis. Mean values for TLC were 132 ± 3.3 HU, 186 ± 5.8 HU and 168 ± 2.8 HU for protocols A, B and C. Protocol B provided significantly higher TLC than protocols A and C (p < 0.001). TLC was significantly higher using an imaging delay of 8 s compared with a delay of 4 or 12 s. • C-arm cone-beam CT (CACT) angiography offers additional information during hepatic intervention. • CACT hepatic arteriography tumour-to-liver contrast is highest with an 8-s delay. • An 8-s delay is recommended for early arterial phase CACTHA for hepatocelullar carcinoma.
- 1 November 2012
- Published by Elsevier in European Journal of Radiology
- Vol. 81 (11) , 2990-2995
Hepatic steatosis assessment with 1H-spectroscopy and chemical shift imaging at 3.0T before hepatic surgery: Reliable enough for making clinical decisions?
- 1 November 2012
- Published by Elsevier in European Journal of Radiology
- Vol. 81 (11) , 2990-2995
Hepatic steatosis assessment with 1H-spectroscopy and chemical shift imaging at 3.0T before hepatic surgery: Reliable enough for making clinical decisions?
- 1 June 2011
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 259 (3) , 757-766
Gadobenate Dimeglumine–enhanced 3.0-T MR Imaging versus Multiphasic 64–Detector Row CT: Prospective Evaluation in Patients Suspected of Having Pancreatic Cancer
To compare the diagnostic performance (detection, local staging) of multiphasic 64-detector row computed tomography (CT) with that of gadobenate dimeglumine-enhanced 3.0-T magnetic resonance (MR) imaging in patients suspected of having pancreatic cancer. The institutional review board approved this prospective study, and all patients provided written informed consent. Multidetector CT and MR imaging were performed in 89 patients (48 women aged 46-89 years [mean, 65.6 years] and 41 men aged 46-86 years [mean, 65.3 years]) suspected of having pancreatic cancer on the basis of findings from clinical examination or previous imaging studies. Two readers independently assessed the images to characterize lesions and determine the presence of focal masses, vascular invasion, distant metastases, and resectability. Findings from surgery, biopsy, endosonography, or follow-up imaging were used as the standard of reference. Logistic regression, the McNemar test, and κ values were used for statistical analysis. Focal pancreatic masses were present in 63 patients; 43 patients had adenocarcinoma. For reader 1, the sensitivities and specificities in the detection of pancreatic adenocarcinoma were 98% (42 of 43 patients) and 96% (44 of 46 patients), respectively, for CT and 98% (42 of 43 patients) and 96% (44 of 46 patients) for MR imaging. For reader 2, the sensitivities and specificities were 93% (40 of 43 patients) and 96% (44 of 46 patients), respectively, for CT and 95% (41 of 43 patients) and 96% (44 of 46 patients) for MR imaging. Vessel infiltration was determined in 22 patients who underwent surgery, and reader 1 obtained sensitivities and specificities of 90% (nine of 10 vessels) and 98% (119 of 122 vessels), respectively, for CT and 80% (eight of 10 vessels) and 96% (117 of 122 vessels) for MR imaging; for reader 2, those values were 70% (seven of 10 vessels) and 98% (120 of 122 vessels) for CT and 50% (five of 10 vessels) and 98% (120 of 122 vessels) for MR imaging. Both readers correctly assessed resectability in 87% (13 of 15 patients) of cases with CT and 93% (14 of 15 patients) of cases with MR imaging. Nonresectability was assessed correctly with CT in 75% (six of eight patients) of cases by reader 1 and 63% (five of eight patients) of cases by reader 2; nonresectability was correctly assessed with MR imaging in 75% (six of eight patients) of cases by reader 1 and 50% (four of eight patients) of cases by reader 2. None of the differences between modalities and readers were statistically significant (P > .05). Both CT and MR imaging are equally suited for detecting and staging pancreatic cancer. http://radiology.rsna.org/lookup/suppl/doi:10.1148/radiol.11101189/-/DC1.
- 1 June 2011
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 259 (3) , 757-766
Gadobenate Dimeglumine–enhanced 3.0-T MR Imaging versus Multiphasic 64–Detector Row CT: Prospective Evaluation in Patients Suspected of Having Pancreatic Cancer
To compare the diagnostic performance (detection, local staging) of multiphasic 64-detector row computed tomography (CT) with that of gadobenate dimeglumine-enhanced 3.0-T magnetic resonance (MR) imaging in patients suspected of having pancreatic cancer. The institutional review board approved this prospective study, and all patients provided written informed consent. Multidetector CT and MR imaging were performed in 89 patients (48 women aged 46-89 years [mean, 65.6 years] and 41 men aged 46-86 years [mean, 65.3 years]) suspected of having pancreatic cancer on the basis of findings from clinical examination or previous imaging studies. Two readers independently assessed the images to characterize lesions and determine the presence of focal masses, vascular invasion, distant metastases, and resectability. Findings from surgery, biopsy, endosonography, or follow-up imaging were used as the standard of reference. Logistic regression, the McNemar test, and κ values were used for statistical analysis. Focal pancreatic masses were present in 63 patients; 43 patients had adenocarcinoma. For reader 1, the sensitivities and specificities in the detection of pancreatic adenocarcinoma were 98% (42 of 43 patients) and 96% (44 of 46 patients), respectively, for CT and 98% (42 of 43 patients) and 96% (44 of 46 patients) for MR imaging. For reader 2, the sensitivities and specificities were 93% (40 of 43 patients) and 96% (44 of 46 patients), respectively, for CT and 95% (41 of 43 patients) and 96% (44 of 46 patients) for MR imaging. Vessel infiltration was determined in 22 patients who underwent surgery, and reader 1 obtained sensitivities and specificities of 90% (nine of 10 vessels) and 98% (119 of 122 vessels), respectively, for CT and 80% (eight of 10 vessels) and 96% (117 of 122 vessels) for MR imaging; for reader 2, those values were 70% (seven of 10 vessels) and 98% (120 of 122 vessels) for CT and 50% (five of 10 vessels) and 98% (120 of 122 vessels) for MR imaging. Both readers correctly assessed resectability in 87% (13 of 15 patients) of cases with CT and 93% (14 of 15 patients) of cases with MR imaging. Nonresectability was assessed correctly with CT in 75% (six of eight patients) of cases by reader 1 and 63% (five of eight patients) of cases by reader 2; nonresectability was correctly assessed with MR imaging in 75% (six of eight patients) of cases by reader 1 and 50% (four of eight patients) of cases by reader 2. None of the differences between modalities and readers were statistically significant (P > .05). Both CT and MR imaging are equally suited for detecting and staging pancreatic cancer. http://radiology.rsna.org/lookup/suppl/doi:10.1148/radiol.11101189/-/DC1.
- 7 April 2009
- Published by Georg Thieme Verlag KG in RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
- Vol. 181 (06) , 587-592
Gadoxate-Enhanced T 1-Weighted MR Cholangiography: Comparison of 1.5 T and 3.0 T
Ziel: Vergleich der Gadoxate-verstärkten T 1-gewichteten Cholangiografie bei 1,5 T und 3,0 T Feldstärke. Material und Methoden: 40 Patienten mit nicht dilatierten Gallenwegen wurden in diese retrospektive Studie eingeschlossen. Eine T 1-gewichtete MR-Cholangiografie 20 min nach i. v. Applikation von 0,025 mmol/kg Gadoxate (Primovist™) wurde bei 20 Patienten bei 1,5 T Feldstärke angefertigt. Die anderen 20 Patienten wurden bei 3,0 T Feldstärke untersucht. Das Kontrast-Rausch-Verhältnis des Gallensystems (Ductus hepatocholedochus – DHC; Ductus hepaticus dexter – DHD; Ductus hepaticus sinister – DHS) im Vergleich zum umgebenden Gewebe wurde gemessen. Darüber hinaus wurde eine qualitative Analyse von 2 Radiologen durchgeführt, wobei die Sichtbarkeit der intra- und extrahepatischen Gallenwege mittels einer 6-Punkte-Skala evaluiert wurde. Die statistische Auswertung erfolgte mittels Mann-Whitney-U-Test und Pearson-Korrelation-Koeffizient. Ergebnisse: Die Kontrast-Rausch-Verhältnisse der intra- und extrahepatischen Gallenwege waren bei 3,0 T signifikant höher als bei 1,5 T. Die qualitative Analyse zeigte eine signifikant bessere Abgrenzbarkeit der intrahepatischen Gallenwege (DHD, DHS, segmentale Gallenwege) bei 3,0 T Feldstärke. Schlussfolgerung: Die Gadoxate-verstärkte T 1-gewichtete MR-Cholangiografie bei 3,0 T ermöglicht eine bessere Darstellung der intrahepatischen Gallenwege als bei 1,5 T. Purpose: To qualitatively and quantitatively compare gadoxate-enhanced T 1-weighted MR cholangiography at magnetic field strengths of 1.5 T and 3.0 T. Materials and Methods: A total of 40 patients with a non-dilated biliary system were retrospectively included in the study. T 1-weighted MR cholangiography 20 min after IV administration of 0.025 mmol/kg gadoxate (Primovist™) was performed in 20 patients at 1.5 T and in another 20 patients at 3.0 T. Contrast-to-noise ratios (CNR) of the biliary system (common bile duct – CBD, right hepatic duct – RHD, left hepatic duct – LHD) compared to the periductal tissue were measured. Two radiologists also qualitatively assessed the visibility of the intrahepatic and extrahepatic biliary system using a six-point rating scale. The Mann-Whitney U-test and Pearson’s correlation coefficient were used for statistical analysis. Results: The CNRs of the intrahepatic and extrahepatic hepatic bile ducts were significantly higher at 3.0 T. Qualitative analysis showed a significant superiority for 3.0 T in the delineation of the intrahepatic biliary system (RHD, LHD, segmental ducts). Conclusion: Gadoxate-enhanced T 1-w MR cholangiography at 3.0 T offers better delineation of the intrahepatic biliary system in comparison to imaging at 1.5 T.
- 7 April 2009
- Published by Georg Thieme Verlag KG in RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren
- Vol. 181 (06) , 587-592
Gadoxate-Enhanced T 1-Weighted MR Cholangiography: Comparison of 1.5 T and 3.0 T
Ziel: Vergleich der Gadoxate-verstärkten T 1-gewichteten Cholangiografie bei 1,5 T und 3,0 T Feldstärke. Material und Methoden: 40 Patienten mit nicht dilatierten Gallenwegen wurden in diese retrospektive Studie eingeschlossen. Eine T 1-gewichtete MR-Cholangiografie 20 min nach i. v. Applikation von 0,025 mmol/kg Gadoxate (Primovist™) wurde bei 20 Patienten bei 1,5 T Feldstärke angefertigt. Die anderen 20 Patienten wurden bei 3,0 T Feldstärke untersucht. Das Kontrast-Rausch-Verhältnis des Gallensystems (Ductus hepatocholedochus – DHC; Ductus hepaticus dexter – DHD; Ductus hepaticus sinister – DHS) im Vergleich zum umgebenden Gewebe wurde gemessen. Darüber hinaus wurde eine qualitative Analyse von 2 Radiologen durchgeführt, wobei die Sichtbarkeit der intra- und extrahepatischen Gallenwege mittels einer 6-Punkte-Skala evaluiert wurde. Die statistische Auswertung erfolgte mittels Mann-Whitney-U-Test und Pearson-Korrelation-Koeffizient. Ergebnisse: Die Kontrast-Rausch-Verhältnisse der intra- und extrahepatischen Gallenwege waren bei 3,0 T signifikant höher als bei 1,5 T. Die qualitative Analyse zeigte eine signifikant bessere Abgrenzbarkeit der intrahepatischen Gallenwege (DHD, DHS, segmentale Gallenwege) bei 3,0 T Feldstärke. Schlussfolgerung: Die Gadoxate-verstärkte T 1-gewichtete MR-Cholangiografie bei 3,0 T ermöglicht eine bessere Darstellung der intrahepatischen Gallenwege als bei 1,5 T. Purpose: To qualitatively and quantitatively compare gadoxate-enhanced T 1-weighted MR cholangiography at magnetic field strengths of 1.5 T and 3.0 T. Materials and Methods: A total of 40 patients with a non-dilated biliary system were retrospectively included in the study. T 1-weighted MR cholangiography 20 min after IV administration of 0.025 mmol/kg gadoxate (Primovist™) was performed in 20 patients at 1.5 T and in another 20 patients at 3.0 T. Contrast-to-noise ratios (CNR) of the biliary system (common bile duct – CBD, right hepatic duct – RHD, left hepatic duct – LHD) compared to the periductal tissue were measured. Two radiologists also qualitatively assessed the visibility of the intrahepatic and extrahepatic biliary system using a six-point rating scale. The Mann-Whitney U-test and Pearson’s correlation coefficient were used for statistical analysis. Results: The CNRs of the intrahepatic and extrahepatic hepatic bile ducts were significantly higher at 3.0 T. Qualitative analysis showed a significant superiority for 3.0 T in the delineation of the intrahepatic biliary system (RHD, LHD, segmental ducts). Conclusion: Gadoxate-enhanced T 1-w MR cholangiography at 3.0 T offers better delineation of the intrahepatic biliary system in comparison to imaging at 1.5 T.
- 10 May 2007
- Published by Springer Nature in European Radiology
- Vol. 17 (11) , 2934-2940
Two K versus 4 K storage phosphor chest radiography: detection performance and image quality
The purpose of this study was to evaluate the effect of matrix size (4-K versus 2-K) in digital storage phosphor chest radiographs on image quality and on the detection of CT-proven thoracic abnormalities. In 85 patients who underwent a CT of the thorax, we obtained two additional posteroanterior storage phosphor chest radiographs, one with a matrix size of 3,520×4,280 (=4-K) and the other with a matrix size of 1,760×2,140 (=2-K). Acquisition, processing and presentation parameters were identical for all radiographs. Two radiologists evaluated the presence of mediastinal, pleural, and pulmonary abnormalities on hard copies of the radiographs, applying ROC analysis. In addition, four radiologists were asked to subjectively rank differences in image quality and to assess the demarcation of anatomic landmarks comparing the images in a blinded side-by-side manner. These data were analyzed using a two-sided binomial test with a significance level of P<0.05. Both tests, the ROC analysis of the detection performance and the binomial test of the subjective quality ratings, did not reveal significant differences between the two matrix sizes. Compared to 2-K radiographs, 4-K storage phosphor chest radiographs do not provide superior detection performance or image quality when evaluated in identical hard copy formats.
- 10 May 2007
- Published by Springer Nature in European Radiology
- Vol. 17 (11) , 2934-2940
Two K versus 4 K storage phosphor chest radiography: detection performance and image quality
The purpose of this study was to evaluate the effect of matrix size (4-K versus 2-K) in digital storage phosphor chest radiographs on image quality and on the detection of CT-proven thoracic abnormalities. In 85 patients who underwent a CT of the thorax, we obtained two additional posteroanterior storage phosphor chest radiographs, one with a matrix size of 3,520×4,280 (=4-K) and the other with a matrix size of 1,760×2,140 (=2-K). Acquisition, processing and presentation parameters were identical for all radiographs. Two radiologists evaluated the presence of mediastinal, pleural, and pulmonary abnormalities on hard copies of the radiographs, applying ROC analysis. In addition, four radiologists were asked to subjectively rank differences in image quality and to assess the demarcation of anatomic landmarks comparing the images in a blinded side-by-side manner. These data were analyzed using a two-sided binomial test with a significance level of P<0.05. Both tests, the ROC analysis of the detection performance and the binomial test of the subjective quality ratings, did not reveal significant differences between the two matrix sizes. Compared to 2-K radiographs, 4-K storage phosphor chest radiographs do not provide superior detection performance or image quality when evaluated in identical hard copy formats.